upper lip include a flattening of the philtrum, widening of the Cupid's bow, and loss of the natural "pout" of the vermilion. Orbicularis muscle activity and thinning of the tissues result in the occurrence of radial lip lines, with unsightly "wicking" of lipstick into the furrows as they cross the white line. All of these factors drive patients to seek lip augmentation. Often, when a patient presents for treatment, the upper lip dominates the discourse, but the lower lip may require treatment as well. With age, the lower lip may develop ptosis, with a resulting unattractive lower dental show.
The objective of lip augmentation is a natural threedimensional (3-D) enhancement of lip volume with welldefined vermilion border. The goal for the upper lip is a change in form that harmonizes with the patient's unique features while avoiding overcorrection. The goal for the lower lip is to add bulk, greater prominence, and projection of the vermilion-all in proportion with the upper lip.
Lip dimensions and their relation to the whole face have been discussed mainly in the dental literature. 8 There have been few attempts to scientifically measure the degree of lip augmentation, regardless of method. Some have attempted to quantify changes in lip volume with magnetic resonance imaging (MRI) 9, 10 and computerized 3-D stereophotogrammetry. 11, 12 However, these sophisticated, complex, and expensive methods are not practical as an office assessment or as part of clinical routine. Carruthers et al 13 described a five-point photonumeric rating scale (Lip Fullness Grading Scale [LFS]) from a series of morphed and unretouched lip photos. As with many analog rating scales, 14 accurate reproduction and consistency are difficult to achieve because the "rating" depends on the subjective judgment of the observer. Clearly, a reproducible means of injectable delivery and an objective method for measuring results over time are both necessary. To that end, we describe the development of an objective Lip Index (LI) for quantifying the results of lip augmentation procedures. We designed our LI based on the protrusion and height (in mm) of the upper and lower vermilion in two standardized photos of 40 patients. With this index, when lips thin out during aging and/or when they are augmented, lip protrusion and height can be measured on comparable photos months or years later, and the effect of enhancement or aging can be documented accurately.
METHODS
Photographs were taken of each patient from a standardized frontal and a 90-degree side view with a camera setup offering chin support and a fixed distance, in front of a light background. The lips were 1 to 2 mm loosely open, to show the incisors ( Figure 1A and 1B) . The size of the photo correlated with the clinical size of the lips. (For comparison, the width of the lips can be measured from the right to the left commissure and compared with the width on the photo.)
Measurements were taken directly from each patient, from standardized photos, or from the computer screen.
We designed a convenient device for measuring the lips, consisting of two small rulers glued together perpendicularly, at a 90-degree angle ( Figure 1C The fullness measurement of lips appears to have no mathematical relationship to surrounding features such as nose, chin, or cheeks, 13, 15 although fullness does appear to correspond to racial origins. For these reasons, it probably means little to calculate mean volumes and standard deviations in attempts to define ideal lip physiognomy. Relative to LI calculation, every patient is best treated as a singularity, comparing the LI only to that patient's variation over time.
Injection Technique
The goal of lip filling may be more than to simply augment. Lip recontouring is undertaken to improve shape and bring upper and lower lips into better proportion with one another. The ideal proportion is the ratio of 1:1.6 between upper and lower lip 2 ( Figure 2A ). There are three small tubercles on the upper lip and two on the lower lip, 2, 16 which give the shape of the lips its individuality and should therefore be preserved during augmentation.
Collagen, hyaluronic acid (HA) products, and liquid silicone (LIS) have all been injected intramuscularly in lips. 1, 4 However, all such intramuscular injections are prone to dislocation by constant muscle movement and therefore may cause lumping. 5, 17, 18 Experience dictates that all particle-based injectables such as ArteFill (Suneva Medical, Inc., San Diego, California), Radiesse (Bioform Medical, Inc., San Mateo, California), and Sculptra (Sanofi-Aventis, Bridgewater, New Jersey)-none of which are approved by the Food and Drug Administration (FDA) for lip treatment-should strictly be administered either along the vermilion borders and/ or submucosally along the dry-wet border, avoiding intramuscular placement ( Figure 2B ). In this case, the ULH could also be measured laterally from the midline (17 mm). The lower lip height (LLH) is 22 mm. (B) A line is drawn from the columella-lip junction to the horizontal chin fold, and the maximal protrusion of the lips is measured perpendicular to this line (ULH = 8 mm, LLH = 7 mm). (C) To recreate the authors' measuring device, a short mm measure should be cut from the end of a simple metric ruler and then attached to the other piece in a perpendicular fashion. The horizontal part of the ruler measures the protrusion of the lips from an imaginary line between the base of the nose and the horizontal chin fold (either directly on the patient or on the computer screen). The ratio should be 1:1.
We have found that the ideal needle size is 30-gauge and its length is one-half inch. This small needle also works with higher viscosity injectables like the three mentioned earlier. The smaller the needle diameter, the smaller the initial volume injected. However, the smaller the needle, the longer the postshot oozing from the needle tip. To minimize this oozing during the microdroplet injection technique, we recommend a short 26-gauge needle for the inner submucosal injection of high-viscous products. The upper and lower lips are best anesthetized by lidocaine injections into the labiogingival fold 19 that numb the lips within two minutes.
Beneath the vermilion border appears a natural, loose interstitial plane between the skin of the white roll and the underlying orbicularis oris muscle. This plane is easily located and may be augmented with the filler (Figure 2B ). One may readily direct the needle into the correct plane at an angle from lateral to medial or vice versa (Figure 2A ). While injecting, it is often useful to hold the white roll between two fingers in order to prevent filler dislocation. Usually, filler can be implanted in half of the lip in a single penetration by withdrawing the needle from the white roll while injecting under pressure. A volume of 0.4 to 0.8 mL should be sufficient for each lip. Larger volumes may result in overdistention and pain. If large corrections are indicated, it is better to augment the lips in stages. If the injectable is well tolerated and the lips are soft after three months, more injectate can be introduced in the same tissue plane. To increase fullness and protrusion ("pouting") of the lip, a second volume can be applied horizontally along the dry-wet border (red line) of the inner vermilion. In this location in the lip, the serial puncture technique must be used exclusively to prevent clumping of the filler during early lip movement.
As noted previously, particulate materials such as ArteFill, Radiesse, and Sculptra have no FDA approval for lip augmentation because of the history and potential danger of resulting lumps. These materials should never be implanted into the orbicularis oris muscle because this may cause dislocation of the injectate and nodule formation. The patient must be aware that longer-lasting fillers implanted submucosally can nearly always be felt with the tongue or the teeth and may appear white in color when the lip is stretched. Sensitivity to strong touch and firm kissing may last up to one year, but usually resolves spontaneously.
A flattened philtrum may be raised effectively with two vertical injections of filler along the philtral ridges, starting from below (ie, from the two peaks or tubercles of the Cupid's bow within the white roll, 2,16 extending vertically to just below the nasal sill). Occasionally, fluid injectables may migrate into the surrounding tissue during the injection. Immediate correction is possible by molding the implant between two fingers into the philtrum ridge or the white roll. The proper injection technique entails linear threading 19 of the injectable along the desired path. The serial puncture technique should be studiously avoided in the visible part of the lip. When the upper lip is long and dental show is lessthan-desirable as a result (as with the patient in Figure 6) , injection of filler material should be avoided. Doing so may further lengthen the lip and hide the front teeth on smiling. In these patients, a surgical lip lift (subnasal bullhorn excision) may be preferable.
The primary complication with injectables in the lips, observed to varying degrees with all fillers, has been the formation of nodules 17, 18, 20 and granulomas. 15, [21] [22] [23] [24] [25] The absence of strictly-reproducible injection techniques and the variability among patients certainly adds to the uncertainty and lack of consistency in results. Irregularities usually reflect lack of technical skill and experience of the injector, whereas lumpiness most often is due to the constant movement of the orbicularis oris muscle, which compresses each strand of any injectable into a lump during uncontrolled pouting. Fluid fillers such as collagen, silicone, and HA may dissipate within or outside the muscle when injected intramuscularly. Permanent and semipermanent fillers such as ArteFill, Radiesse, or Sculptra will remain where injected due to their higher viscosity. For this reason, we strongly advocate avoiding the orbicularis muscle during injection, instead delivering the product in the subcutaneous or submucosal fat.
RESULTS
Figures 3 to 7 illustrate the ease and reliability of measurements and results with our OLI calculations. Of course, unilateral vermilion components can be measured as well in patients with asymmetries and unilateral cleft lips 26, 27 ( Figure 8 ). Edematous or lumpy lips caused by filler granulomas or other etiologies can be measured over time, and the effectiveness of corrective treatment can thereby be documented.
DISCUSSION
There appears to be an ever-expanding list of commercial products that have potential for lip augmentation. In Europe, we estimate that there are more than 50 dermal fillers on the market. There are also a number of autologous materials (such as fat, fascia, and tendon) that may be employed to augment the lips. Despite the plethora of modalities, there are very few published sources of technical information or guidelines to assist the practitioner with the correct technique for lip enhancement.
The most common approach to lip augmentation is the use of commercially available dermal fillers. 9 There is a broad range of expected outcomes with injectables, depending on the skills of the injector, the anatomy of the patient, and the intrinsic properties of the product. Resurfacing techniques for lip skin are also available, including dermabrasion, laser, or chemical peels, thereby adding to the nearly infinite number of permutations that may be employed for lip rejuvenation. 4 In the decades immediately prior to this century, lip augmentation options were limited mainly to silicone injections or implants, 7, 28 bovine collagen injections, 21 and a few surgical procedures. Several new injectable dermal fillers have become available over the past decade. These include extracellular connective tissue components such as HA 22, 26 and porcine collagen (Evolence; not available in the United States). 20, [29] [30] [31] Injectable products that offer more long-term, durable results are also evolving and becoming available on the market. These injectables derive their longevity from microspheres of polylactic acid, 23 calcium phosphate, 17, 24 and polymethylmethacrylate. 19 Although lip augmentation may not be an indication under approved labeling (and is not recommended by any manufacturer), a body of clinical data is slowly evolving for this application. In addition to injectables, solid, soft alloplastic implants from expanded PTFE (Advanta Facial Implant; Atrium Medical Corporation, Hudson, New Hampshire), 11, [32] [33] [34] silicone (PermaLip; SurgiSil, LLP, Plano, Texas), and salinefilled ePTFE-silicone shells (FulFil and VeraFil; Evera Medical, Foster City, California) 35 have been described as bulking agents and implants for lip augmentation. Finally, autogenous grafts of fat, 27, [36] [37] [38] temporal fascia, and palmaris longus tendon 39, 40 have been used in attempts at permanent lip augmentation. The autogenous tissue approach so far has been largely anecdotal and difficult to reproduce with consistency. 27, [36] [37] [38] Regardless of the augmentation material chosen, over time, our LI enables a practitioner to follow the results of lip augmentation and accurately assess the longevity and efficacy of various augmentation techniques, without having to resort to complex and difficult mathematical formulas. For example, it is easy to ascertain a baseline Caucasian OLI of 30 mm 2 , observe an enhancement effect with treatment that may cause the OLI to increase to 100 mm 2 , and then follow it over time to judge when additional correction may be warranted. 
CONCLUSIONS
To assess lip volume and follow it over time in individual patients, the authors designed a simple, straightforward measurement method, referred to as the Overall Lip Index (OLI). The OLI allows for the practical evaluation of the clinical effects and duration of dermal filler injectables or implants after lip enhancement. Quantitative assessments of results over time are easy to calculate, without the need for complex measurements or sophisticated analyses.
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